Nike shares sink in extended trading on weaker-than-expected revenue

Randy Konik, Jefferies, joins 'Closing Bell Overtime' with reaction to Nike's mixed results.

Rapid Recap: Nike's stock has struggled as it faces stiff competition - here’s what experts say

CNBC's Jim Cramer, BTIG's Bob Drbul, Evercore ISI's Michael Binetti, and Permanent Portfolio's Michael Cuggino weigh in on ...

Allianz's Mohamed El-Erian on 10-year yield's easing back from earlier spike

Erian, Allianz chief economic advisor, joins 'Closing Bell' to discuss the 10-year yield pulling back from a 24-year high on ...

Nike has its challenges but macro environment made challenges more difficult, says Oppenheimer’s Brian Nagel

Brian Nagel, Oppenheimer analyst, joins 'Closing Bell' to discuss Nike earnings. Got a confidential news tip? We want to hear ...

Alphabet shares slide as Gemini 4 launch disappoints the Street

CNBC’s MacKenzie Sigalos reports on Google’s restricted rollout of Gemini 4 Argon, Meta’s growing lead in personal AI agents, ...

Mattel shares rise after reports of takeover interest from Authentic Brands Group

Shares of toymaker Mattel rose Thursday after the Wall Street Journal reported that Authentic Brands Group had expressed ...

Boeing engineers and technical workers approve new contract, avoiding strike

Boeing engineers and technical workers approved a sweetened four-year contract with immediate 10% raises, avoiding a potential strike at the aerospace giant as it seeks federal ap ...

Midterms likely to be a positive catalyst going into the end of the year, Taylor Group’s James Taylor

Andrew Slimmon, Morgan Stanley Investment senior portfolio manager, and James Taylor, Taylor Group of Wells Fargo Advisors ...

Jim Cramer sees a huge catalyst on the horizon for Apple. How to play the stock

Keep your bat on your shoulder and be ready to swing if Apple shares wobble ahead of this month's foldable iPhone release, ...

One drug, many rare diseases. Inside the movement to make rare drug development more profitable

The Ladders to Cures Accelerator aims to develop treatments for multiple rare diseases through shared biological mechanisms.

Generate more portfolio income in volatile times with these options strategies

September was a bumpy ride for stocks and bonds, but strategies using options can help investors generate a little more portfolio income. Last month, the S & P 500 slipped 0.5% as higher oil prices, ...